Cell invasion was evaluated using cell Invasion Assay Kit (Chemicon) following the manufacturer's instructions. In brief, cells were serum-starved 16 h before seeding, and 10% FBS was used as a chemoattractant. After 24 h, noninvaded cells were wiped off using a cotton swab, and Genes modulated by PEDF in melanoma Orgaz et al. 287
Pigment epithelium-derived factor (PEDF) is a broadspectrum angiogenesis inhibitor that displays potent antimetastatic activity in multiple tumor types. We have previously shown that PEDF prevents primary tumor growth and metastatic spread of human melanoma in mouse experimental models. Consistent with these observations, PEDF expression is lost at the late stages of melanoma progression, allowing melanoma cells to become angiogenic, migratory, and invasive. PEDF's ability to modify the interplay between the host and tumor tissues strongly supports its use as a therapeutic agent for the treatment of metastatic melanoma. However, transition to the clinic requires a more detailed knowledge of the molecular mechanisms underpinning PEDF's activity. In this study, we describe changes in the gene expression profile of A375 human melanoma cells induced by PEDF overexpression. PEDF modulated diverse categories of genes known to be involved in angiogenesis and migration. It downregulated cytokines such as interleukin-8 and extracellular matrix proteins such as collagen IV, while it upregulated fibronectin. Multiple transcripts previously described as contributing to the acquisition of malignant phenotype by melanoma were also diminished by PEDF overexpression, among which we validated galectin 3 and jagged 1. In addition, PEDF downregulated S100b and melanoma inhibitory activity, which are widely used in the pathological diagnosis of melanoma. Interestingly, PEDF increased the expression of melanophilin and decreased rab27A, which are relevant targets for melanosome transport; suggesting that PEDF could directly impinge on melanocytic lineage-specific processes. Our study identifies new molecular targets and signaling pathways that may potentially contribute to determine PEDF's ability to restrict the aggressiveness of A375 human melanoma cells. 
Introduction
Angiogenesis, the formation of new blood vessels from preexisting ones [1] , is an essential process for tumor growth maintenance, dissemination, and metastasis growth [2] . Angiogenesis is regulated by the dynamic balance between two general types of regulators, inducers (proangiogenic), and inhibitors (antiangiogenic). In normal tissues, vascular quiescence is maintained because of a predominance of inhibitors, whose blocking action is dominant over a wide array of inducers [3, 4] . However, during tumor progression, the angiogenic balance is inverted by genetic alterations as well as epigenetic regulation, which determine a predominance of inducers over inhibitors [5] . Strict dependency of tumor growth and dissemination on sustained angiogenesis prompted the design of new therapeutic strategies for cancer treatment based on angiogenesis blockade, either by using neutralizing antibodies to relevant angiogenic factors or to their signaling receptors. Despite major impact of these strategies on preclinical models [6] , both preclinical and clinical studies show that when a single angiogenic factor is targeted, the tumors acquire resistance to therapy, most likely because of production of alternative angiogenesis inducers [7] . To overcome these limitations a number of alternative approaches are currently being tested [8] [9] [10] [11] . One such strategy involves restoration of endogenous Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.melanoma.com).
angiogenesis inhibitors, whose expression is lost during malignant progression and which block the action of multiple inducers [11] . Treatment of xenografted tumors with endogenous antiangiogenic factors efficiently halts primary tumor growth and significantly impairs metastasis [12] [13] [14] . However, translating endogenous inhibitors of angiogenesis into the clinic requires deeper knowledge of their biological effects and underlying molecular mediators.
Pigment epithelium-derived factor (PEDF) is a 50 kDa secreted glycoprotein and a nonfunctional member of the serine protease inhibitor (Serpin) superfamily [15, 16] . PEDF plays a critical role in maintaining vascular quiescence and controls the angiogenic switch in multiple tissues [17, 18] . Potent antitumor and antimetastatic effects of PEDF were demonstrated in mouse experimental models using a variety of cancer cell lines, and an inverse correlation between PEDF levels and aggressiveness was also shown for different types of cancers [19] . We have previously described the antitumor and antimetastatic effects of PEDF on melanoma [19, 20] , a type of cancer that displays a relevant angiogenic activity [21, 22] . The ability of PEDF to inhibit melanoma growth and metastasis is based on its dual action on endothelial and tumor cells. In both cell types, PEDF can cause apoptosis and impair migratory and invasive capacity. Recent reports have identified nonoverlapping epitopes on PEDF molecule responsible for its diverse biological actions [23] [24] [25] . We have also found that PEDF is expressed at high levels in normal skin melanocytes, and that the loss of PEDF expression enables the switch of melanoma cells from proliferative to invasive phenotype, highlighting the relevance of this factor in the control of melanoma progression [26] . Thus we propose that restoration of PEDF expression by delivery of recombinant PEDF or short PEDF-derived peptides could be used as a therapeutic strategy in advanced melanoma, which is an especially aggressive cancer refractory to currently available drugs [27] . Use of this multifaceted factor, which targets diverse biological processes critical for cancer progression, may serve a double purpose, that is, obliterating the vasculature and switching off their ability to invade, leading to reduced metastatic spread of melanoma cells [19] . Despite the interesting biological properties described for PEDF, a detailed understanding of its molecular mechanisms remains elusive.
In this study, we identify novel candidate factors and pathways that could mediate the effects of PEDF on A375 human melanoma cells. Using global gene expression profiling analysis, we have found that PEDF overexpression in A375 cells mostly downregulated distinct sets of genes, which fall into several functional categories including the control of angiogenesis and several other functions required for melanoma progression; although it increased expression of some relevant transcripts such as fibronectin and melanophilin (MLPH). Identified targets provide a molecular insight into the actions of PEDF leading to reduced aggressiveness of A375 melanoma cells.
Materials and methods
Cell culture A375 human melanoma cell line, originally established in culture from a lymph node metastasis of a melanoma patient [28, 29] , was kindly provided by Dr Vidal-Vanaclocha (Universidad del Pais Vasco, Bilbao, Spain). UCD-Mel-N human melanoma cell line was originally derived from a patient with multiple primary melanoma tumors, and generously provided by Medrano [30] . C8161 human melanoma cell line was initially isolated from an abdominal wall metastasis of a cutaneous melanoma patient, and generously provided by Hendrix [31] . All melanoma cell lines were grown in Dulbecco's modified Eagle's medium (Gibco, New York, New York, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco), 2 mmol/l glutamine (Gibco), 50 mg/ml streptomycin (Gibco), 50 U/ml penicillin (Gibco), and 2.5 mg/ml fungizone (Sigma, St Louis, Missouri, USA).
Generation of pigment epithelium-derived factor overexpressing cell lines A375 melanoma cells were seeded into 21-cm 2 plates and 24 h later they were transfected with 10.8 mg pCEP4-PEDF plasmid (provided by Dr Bouck, Northwestern University, Chicago, Illinois, USA) or control pCEP4 plasmid and 21.6 ml jetPEI (Polyplus Transfection, Illkirch, France) for 4 h. Pooled transfected cells (herein after referred to as A375-pCEP4-PEDF Pool and A375-pCEP4 Pool) were selected using 300 mg/ml hygromycin B (Sigma) for 2 weeks and were used for the gene expression profile study. In an independent transfection, a number of isolated clones were selected as described above and used for the validation of target genes identified using the pools. Further validation of selected target genes was carried out by transient overexpression using lentivirus. The lentiviral construct encoding the full-length human PEDF cDNA in the prrl.CMV.EGFP.wpre.SIN lentiviral vector (kindly provided by Dr Bernad, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain) has been previously reported [26] . Lentiviral particles were produced as described earlier [28] . Transduction of A375 melanoma cells was performed by incubating cells with lentiviruses at a multiplicity of infection of 10 in the presence of 8 mg/ml polybrene (Sigma) for 8 h, typically yielding more than 95% transduced [green fluorescent protein (GFP)-positive] cells. After 72 h, PEDF overexpression was assessed in transient studies. PEDF overexpressing UCD-Mel-N and C8161 melanoma cell lines (UCD-PEDF, C8161-PEDF) and their respective controls (UCD-GFP, C8161-GFP) have been described previously [20, 26] .
Western blot
Conditioned media (CM) were prepared and analyzed as described earlier [32] , and 1.5 mg CM were loaded per lane. PEDF monoclonal antibody (Chemicon, Temecula, California, USA) was diluted 1 : 1200.
Interleukin-8 enzyme-linked immunoabsorbant assay
Secreted interleukin-8 (IL-8) protein levels in 48 h CM were quantified using Human CXCL8/IL8 Quantikine ELISA Kit (R&D, Minneapolis, Minneapolis, USA) following manufacturer's instructions.
Reporter assays
We used pGL3-basic reporter plasmids (Promega, Madison, Wisconsin, USA) containing the firefly luciferase gene (Luc) under the control of the -2000 bp fragment of the human IL8 gene promoter (pGL-2000-IL8-Luc, provided by Dr Raingeaud, INSERM, Chatenay-Malabry, France) [33] ; and the pRL-simian virus 40 (SV40) plasmid (Promega) containing the Renilla reniformes luciferase gene (Renilla) under the control of the SV40 virus promoter as a control to correct for the efficiency of transfection. Cells (5 Â 10 4 ) were seeded onto 2-cm 2 wells 24 h before transfection, each condition in triplicate. Then, cells were incubated with 1 ml Lipofectamine 2000 (Sigma), 300 ng pGL-2000-IL8-Luc, and 20 ng pRL-SV40 plasmids in 50 ml OptiMEM (Gibco) per well for 4 h, and later the medium was changed. Next day, cells were incubated with 10% FBS or 10 ng/ml tumor necrosis factor alpha (TNFa) in serum-free medium for 24 h, and then plates were frozen at -801C. Analysis of Luc and Renilla activity was performed using the Dual Luciferase Reporter Assay System (Promega) and a Lumat LB9507 luminometer (Berthold Technologies, Bad Wildbad, Germany). The Luc activity was then normalized to Renilla activity.
RNA extraction and quantitative reverse transcriptase-PCR
Total RNA was extracted using TRIzol (Molecular Research Center Inc., Cincinnati, Ohio, USA) and was retro-transcribed to cDNA using High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, California, USA 
Microarray hybridization and data analysis
Global gene expression profiles of A375-pCEP4 Pool and A375-pCEP4-PEDF Pool cells were determined using whole genome oligonucleotide GeneChip Human Genome-133 plus 2.0 microarrays (Affymetrix, Santa Clara, California, USA). Microarrays were hybridized in duplicate with RNAs from two independent experiments. RNA integrity was determined using a Bioanalyzer 2100 (Agilent Technologies, Palo Alto, California, USA). Biotinylated cRNA was synthesized from total RNA using the 3 0 Amplification One-cycle Target labeling kit (Affymetrix). In brief, 2 mg of RNA were reverse transcribed to produce first strand cDNA using an oligodeoxythymidylic acid 24 primer with a T7 RNA polymerase promoter site added to the 5 0 end. After second strand synthesis, in-vitro transcription was performed using T7 RNA polymerase and biotinylated nucleotides, to produce biotin-labeled cRNA. cRNA (10 mg) was fragmented at 951C for 35 min into 35-200 bases in length. Fragmented cRNAs were hybridized to microarrays at 451C for 16 h in an oven at 60 rpm.
Each microarray was washed and stained in the Affymetrix Fluidics Station 450 following the standard protocols developed by Affymetrix. Microarrays were scanned in an Affymetrix GeneChip Scanner 3000 7G. Normalized gene expression values were obtained using GeneChip robust multi-array average algorithm [34] . To determine statistically significant changes in each individual comparison, we used Microarray Suite (MAS 5.0) comparison analysis from Affymetrix (Statistical Algorithm Reference Guide). In this analysis, a change algorithm generates a change in P value and an associated change (increase, decrease, or no change). Probe sets were considered as regulated when there was a significant change (increase or decrease) and at least a two-fold upregulation or downregulation in A375-pCEP4-PEDF compared with A375-pCEP4 cells in both independent hybridizations (regulated probe sets are listed in Supplementary Table 2 , Supplementary digital content 2 www2.iib.uam.es/bjimenez_lab/SuppTable2.txt). Heat maps of regulated genes were generated using Multiexperimental Viewer software (Microarray Software Suite, http://www.tm4.org). Most regulated genes were classified according to their function into biological process categories from the Gene Ontology database (http:// www.geneontology.org/). This classification was further completed with new 'melanoma progression-related' categories according to information from Gene database (National Center for Biotechnology Information) and published studies in PubMed.
the filters were stained with Diff Quik (Dade Behring, Newark, Delaware, USA). Invaded cells were counted at 10 areas of maximum invasion under a light microscope at Â 40 magnification. Average ± standard deviation values shown are representative of at least three independent experiments.
Statistical analysis
All statistical analyses were carried out using GraphPad Instat (GraphPad Software, San Diego, California, USA). P values less than or equal to 0.05 were considered as significant.
Results

Functional grouping of genes modulated by PEDF in A375 human melanoma cells
To gain insight into the molecular mechanisms underlying effects of PEDF on melanoma, we performed genomewide analysis of the changes in gene expression induced by PEDF overexpression in A375 human melanoma cell line. A375 cells expressed very low endogenous levels of PEDF compared with other human melanoma cell lines tested [26] , and PEDF overexpression significantly reduced its metastatic potential in mouse models [20] . We generated a pool of A375 melanoma cells stably expressing high levels of PEDF (A375-pCEP4-PEDF Pool) and a pool of empty vector-transfected A375 cells (A375-pCEP4 Pool). PEDF expression was assessed by western blot of CM ( Fig. 1a ) and quantitative reverse transcriptase (RT)-PCR ( Fig. 1b ). PEDF overexpression reduced the invasive ability of A375 cells ( Fig. 1c ), in agreement with previously described results in other human melanoma cell lines [20, 26, 35] .
We hybridized RNAs isolated from A375-pCEP4-PEDF Pool and A375-pCEP4 Pool cells to oligonucleotide Affymetrix microarrays. The results from two independent experiments were analyzed. Considering a two-fold cutoff, 757 probe sets showed differential expression (Supplementary Table 2 , Supplementary digital content 2 www2.iib.uam.es/bjimenez_lab/SuppTable2.txt). Among these, 470 corresponded to characterized genes annotated in the National Center for Biotechnology Information. The majority of genes were downregulated by PEDF overexpression (340 genes); whereas 140 genes were upregulated (heat map is shown in Fig. 2a ). The differentially regulated genes were classified according to their function into biological process categories from the Gene Ontology database. We expanded this analysis to include additional categories specifically related to melanoma biology, which are not included at Gene Ontology database, using literature searches for the data supporting the functional role of genes regulated by PEDF ( Fig. 2b and Table 1 ). Significant number of genes (highlighted in the lower boxes in Fig. 2b ) involved in angiogenesis, adhesion, migration, invasion, and matrix degradation were regulated by PEDF. The trend of the regulation was in agreement with its previously described inhibitory effects on melanoma [20] . Interestingly, several genes shown in other studies as relevant for melanoma progression or lineage-specific functions were also modulated by PEDF.
Genes involved in the control of angiogenesis and invasion modulated by PEDF in A375 human melanoma cells
Genes that determine the angiogenic phenotype and the migratory and invasive ability of melanoma cells were modulated by PEDF overexpression in A375 cells ( Fig. 2b and Table 1 ). A number of soluble factors with proangiogenic or chemotactic properties were downregulated upon PEDF overexpression including IL-8, transforming growth factor a and transforming growth factor b-induced (TGFBI) [3] . The downregulation was confirmed by quantitative RT-PCR for IL-8 and transforming growth factor a ( Fig. 3a ) and by enzyme-linked immunoabsorbant assay for IL-8 ( Fig. 3b ).
IL-8 augments the angiogenic potential of melanoma cells and activates their proliferation and migration [36] , and its levels directly correlate with melanoma metastatic potential [37] . Considering the key role of IL-8 in melanoma progression [36] , we sought to further analyze its regulation by PEDF. We confirmed IL-8 downregulation in PEDF-overexpressing A375 clones and UCD-Mel-N and C8161 melanoma cell lines ( Fig. 4 ). We also analyzed the effect of transient PEDF overexpression on IL-8 levels. A375 cells were efficiently transduced (> 95% infected cells) with a lentivirus encoding PEDF (A375lenti-PEDF) or control lentivirus (A375-lenti-GFP) ( Fig. 5a ). PEDF expression was measured 72 h after transduction by western blot of CM ( Fig. 5b ) and quantitative RT-PCR ( Fig. 5c ). IL-8 mRNA ( Fig. 5d ) and protein ( Fig. 5e ) levels were significantly decreased by transient PEDF overexpression. Low levels of IL-8 expression were maintained for at least 2 weeks after lentiviral transduction (data not shown). We also assessed if the decrease in IL-8 expression levels by PEDF was mediated by transcriptional regulation. We analyzed IL-8 promoter activity using a reporter construct encompassing 2000 bp upstream of the IL-8 transcription start site.
In melanoma cells, transiently or stably overexpressing Melanoma inhibitory activity 0.48 0.44 S100A1 S100 calcium binding protein A1 0.33 0.13 S100A13 S100 calcium binding protein A13 0.38 0.33 S100A16 S100 calcium binding protein A16 0.29 0.36 S100A2 S100 calcium binding protein A2 0.30 0.27 S100A3 S100 calcium binding protein A3 0.15 0.12 S100A4 S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) 0.10 0.09 S100B S100 calcium binding protein, PEDF and cultured in 10% serum or treated with TNFa to stimulate IL-8 production [33] , we found no change in the IL-8 promoter activity ( Fig. 5f and data not shown).
Proteases or protease inhibitors from diverse families were predominantly downregulated by PEDF overexpression in A375 cells. This group included tissue inhibitors of metalloproteinases, a disintegrin and metalloproteinase domain, a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, or serine (or cysteine) proteinase inhibitor ( Fig. 2b and Table 1 ). Moreover, PEDF modified the expression of extracellular matrix proteins involved in migration as well as angiogenesis, such as collagen IV (COL4A2) [38] or fibronectin [39] , whose regulation was validated by quantitative RT-PCR ( Fig. 3a) . Even though the downregulation of COL4A2 by PEDF was less than two-fold in the microarray, a more pronounced decrease was found by quantitative RT-PCR. Other factors involved in adhesion and migration, including integrins, cadherins, and protocadherins, were also downregulated in the presence of PEDF ( Fig. 2b and Table 1 ). Furthermore, several molecules of the vascular endothelial growth factor (VEGF) pathway, which could potentially contribute to control of melanoma proliferation and/or migration [22] , such as fms-related tyrosine kinase 1 and neuropilin 2 ( Fig. 2b and Table 1 ), were reduced by PEDF.
Genes implicated in melanoma progression modulated by PEDF in A375 human melanoma cells
Multiple genes previously involved in melanoma progression [40] [41] [42] were modulated by PEDF overexpression in A375 cells with the trend consistent with decreased aggressiveness (Fig. 2b and Table 1 ). This group included genes of the Notch pathway [43] , such as notch homolog 2 and jagged 1 (JAG1); and of the Wnt pathway [44] , including Dickkopf 1 and 3 (DKK1 and DKK3), frizzled 1 and 2 (FZD1, FZD2), and lymphoid enhancer-binding factor 1. The decreased expression of JAG1 in the presence of PEDF was confirmed by quantitative RT-PCR in transfection pools (Fig. 3a) and two independent clones (Fig. 4) . Likewise, PEDF downregulated other genes previously described to participate in melanoma progression by enhancing proliferation or invasion, such as fibroblast growth factor 13 [41] , insulin-like growth factor binding protein 3 (IGFBP3) [45] , inhibin b A [42] and galectin 3 [46] . We validated the regulation of fibroblast growth factor 13, IGFBP3 and galectin 3 by quantitative RT-PCR (Figs 3a and 4) .
PEDF also altered the expression of transcription factors potentially relevant for melanocyte transformation and/or melanoma progression including T-box 2 [47] , SRY (sexdetermining region Y)-box containing gene 2 (SOX2) and SOX5 [48] , which were downregulated; and SOX9 and SOX11 [49] , whose expression was increased. This regulation trend was consistent with reduced tumorigenicity and delayed progression. Moreover, nuclear factor of activated T cells 2, involved in mediating PEDF's intracellular signaling [50] , also had its expression decreased by PEDF ( Fig. 2b and Table 1 ).
Interestingly, a number of melanoma markers whose expression increases in the course of malignant progression were predominantly downregulated in PEDF-overexpressing A375 cells, such as melanoma inhibitory activity (MIA) and several S100 calcium binding protein family members ( Fig. 2b and Table 1 ); the decreased MIA and S100B expression was confirmed by quantitative RT-PCR (Figs 3a and 4) .
Finally, PEDF also diminished the expression of factors involved in the inhibition of apoptosis, such as Bcl2-related protein A1; or in cell proliferation, such as insulin-like growth factor 1 receptor and IGFBP 2, 5 and 7, among others; as well as a number of cytokines and genes involved in metabolism ( Fig. 2b and Table 1 ).
Genes specific for melanocyte lineage functions modulated by PEDF in A375 human melanoma cells
Genes involved in melanocytic lineage-specific functions, such as melanogenesis, were modulated by PEDF overexpression in A375 cells [51] . Melanosomes are specialized membrane vesicles where melanin is synthesized, stored and eventually delivered to the cell membrane, to be transferred to adjacent keratinocytes [52] . Two regulators of melanosome trafficking, the small guanosine triphosphate-binding protein, RAB27A, and its effector melanophilin (MLPH) [53] , were regulated by PEDF overexpression (Fig. 2b and Table 1 ) and this regulation was confirmed by quantitative RT-PCR in transfection pools ( Fig. 3a) and two independent clones (Fig. 4 ).
Discussion
PEDF is an emerging agent for the targeted anticancer therapies. The combination of the potent and diverse effects on tumor cells, as well as its antiangiogenic action; make it especially compelling, particularly for advanced melanoma, a highly aggressive cancer that responds poorly to the currently available treatments. Despite the growing interest in the therapeutic applications of PEDF, very few studies used global expression analysis to seek molecular mediators underlying its multiple biological actions [54] [55] [56] . In this study, we describe genome-wide changes in the expression profile of A375 aggressive human melanoma cells caused by PEDF.
In general, PEDF decreased the expression of numerous genes involved in key tumor-specific functions critical for melanoma progression and whose products are likely to contribute to PEDF known anticancer properties. Genes modulated by PEDF in melanoma Orgaz et al. 293 First, several factors that contribute to angiogenesis and chemotaxis were diminished due to PEDF expression. This is consistent with previous observations by us and others describing PEDF-dependent inhibition of angiogenic potential and motility of melanoma cells [20, 35, 57] . Decreased expression of these genes weakened the ability of melanoma cells to induce neovascularization. The decrease of VEGF mRNA in PEDF-expressing cells was less than two-fold; hence, it was not included in our master list. However, VEGF protein levels were decreased to a larger extent than mRNA [20, 58, 59] , suggesting additional post-transcriptional events. A recent expression profiling study in prostate adenocarcinoma has also shown downregulation of angiogenesis-related genes upon treatment with recombinant PEDF, which included fibroblast growth factor 3, neuropilin 1, brain-specific angiogenesis inhibitor 2, and endothelial PAS domain protein 1 [55] . In our study, neuropilin and fibroblast growth factor family members were also regulated by PEDF in A375 melanoma cells. IL-8, whose expression is also diminished in the presence of PEDF, falls in the same category. IL-8 is a multifunctional cytokine, which stimulates angiogenesis, proliferation, and migration [36] . IL-8 levels directly correlate with the metastatic potential and aggressiveness of melanoma [37, 60] . IL-8 protein and mRNA were significantly decreased due to the transient or stable PEDF overexpression in A375 melanoma cells. However, IL-8 regulation by PEDF in A375 melanoma cells seemed to be mainly post-transcriptional as we were unable to register a decrease in the activity of IL-8 reporter constructs upon PEDF overexpression, despite the presence of multiple binding sites for the transcription factors potentially regulated by PEDF in A375 melanoma cells and other cell types, and involved in IL-8 regulation, such as nuclear factor of activated T cells 2 [50, 61] . The promoter region used in our study has been previously shown to respond to a number of IL-8 stimulating factors including hypoxia [62] , acidosis [63] , TNFa, and IL1 [64] .
Altered expression of adhesion and extracellular matrixrelated molecules by PEDF may, in addition to the chemokine expression, also contribute to PEDF-dependent inhibition of melanoma migration and invasion. In our study, PEDF decreased COL4A2 expression, an essential component of the basement membrane, which is important for angiogenesis, adhesion, and migration [38, 65] . PEDF also enhanced expression of fibronectin, an extracellular matrix protein involved in adhesion, proliferation, and migration through its binding to integrins [39] . Increased fibronectin could enhance cell adhesion that may impair invasiveness. A recent report shows that silencing of fibronectin in thyroid carcinoma cells enhances tumor growth and metastasis [66] .
PEDF overexpression in A375 cells modified the expression of a number of genes attributed in other studies to the malignant progression of human melanoma, including activin A, insulin-like growth factor binding protein 3, and galectin 3, several members of the SOX transcription factor family, and the genes that belong to the Notch (notch homolog 2, JAG1) [43] or Wnt (DKK1, FZD1, lymphoid enhancer-binding factor 1) [44, 67] pathways. Importantly, PEDF downregulated several melanoma markers currently utilized in clinico-pathological diagnosis of melanoma, such as S100b [68] ; or used as prognostic factors for relapse and metastasis, such as S100b or MIA [69] . Collectively, these changes in the expression pattern of the genes related to melanoma progression may reflect the switch to a less aggressive phenotype by PEDF-expressing melanoma cells and supports the therapeutic potential of PEDF in this type of cancer.
Interestingly, PEDF overexpression in A375 cells altered the expression of genes involved in functions specific for melanocyte lineage, upregulating MLPH and downregulating RAB27A. These genes are involved in melanosome trafficking and therefore play a key role in melanin transfer [52] . PEDF has been detected in immature melanosomes of melanoma cells [70] , and prior reports have proposed its participation in pigment production through induction of tyrosinase [71] and promotion of melanosome maturation in retinal pigment epithelium cells [72] .
We have previously described that PEDF is expressed at high levels in melanocytes, and restricts their proliferative and migratory potential [26] . Modulation of MLPH and RAB27A expression by PEDF in A375 cells suggests that it could also mediate melanocyte-specific processes, such as melanin distribution in the skin. In keeping with this new role, we found that PEDF increases the expression of SOX9, which was recently implicated in control of melanocyte differentiation and pigmentation, acting upstream of microphthalmia-associated transcription factor [73] .
In summary, our study points to novel molecular targets and signaling pathways that may potentially contribute to determine PEDF's ability to restrict the aggressiveness of A375 and other human melanoma cells. We also stumbled upon unanticipated PEDF targets involved in melanocytic lineage-specific functions. Our results set the stage for further in-depth studies of the molecular mechanisms underlying PEDF effects in melanoma, which would be essential for the clinical translation of this factor.
